Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Entasis Therapeutics Holdings Inc
(NQ:
ETTX
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Jul 8, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
2.190 (56)
Ask (Size)
2.200 (64)
Prev. Close
2.190
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
47,851,779
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022
October 12, 2022
Six abstracts selected for presentation, including three oral presentations
From
Entasis Therapeutics Holdings Inc.
Via
GlobeNewswire
Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying
July 14, 2022
US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Performance
More News
Read More
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
July 08, 2022
From
Innoviva, Inc.
Via
Business Wire
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
May 23, 2022
Via
Benzinga
Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX
June 03, 2022
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
58 Biggest Movers From Yesterday
May 24, 2022
Via
Benzinga
ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX
May 23, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders
May 23, 2022
From
Halper Sadeh LLP
Via
Business Wire
Innoviva to Acquire Entasis Therapeutics
May 23, 2022
From
Innoviva, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022
May 06, 2022
Via
Benzinga
Entasis Therapeutics Hldg: Q1 Earnings Insights
April 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Via
Benzinga
Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today
March 16, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
March 04, 2022
Via
Benzinga
Recap: Entasis Therapeutics Q4 Earnings
March 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
Via
Benzinga
54 Biggest Movers From Yesterday
February 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 02, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 02, 2022
Via
InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
October 29, 2021
Via
Benzinga
Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
October 23, 2021
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 22, 2021
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 20, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.